GLP-1 Receptor Agonists

One 79-Year-Old Granted Compassionate‑Use Access to Eli Lilly’s Unapproved Obesity Drug

The disclosure has drawn a White House denial that President Trump was the patient, raising ethical concerns about using expanded‑access for a weight‑loss therapy.